Diametric Capital’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Diametric Capital’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-518,134	Closed	-$93.3K	–	413
2025 Q1	$93.3K	Hold	518,134	–	–	0.11%	173
2024 Q4	$339K	Hold	518,134	–	–	0.23%	133
2024 Q3	$196K	Buy	518,134 +184,800	+55%	+$164K	0.1%	310
2024 Q2	$423K	Buy	+333,334	New	+$466K	0.23%	125
2023 Q4	–	Sell	-471,000	Closed	-$3.91M	–	409
2023 Q3	$3.91M	Buy	+471,000	New	+$4.79M	1.64%	6

Diametric Capital's NKGN Position: Q2 2025 in Review

Diametric Capital sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q2 2025, closing a stake of 518,134 shares — an estimated $93.3K sold.

Diametric Capital first reported a position in NKGN in Q3 2023 and held it in 5 quarters. The position peaked at $3.91M in Q3 2023. 0 funds tracked by Wall St. Rank hold NKGN as of Q2 2025.

Diametric Capital reported no remaining NKGen Biotech, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Diametric Capital sold 518,134 NKGen Biotech, Inc. Common Stock shares in Q2 2025, an estimated $93.3K.
Diametric Capital first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
Diametric Capital's NKGen Biotech, Inc. Common Stock position peaked at $3.91M in Q3 2023.
0 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q2 2025.

Based on Diametric Capital's 13F filing for Q2 2025, filed 13 Aug 2025.